37 reports

The Western Equine Encephalitis pipeline guide presents information on all active drugs currently being developed for Western Equine Encephalitis.

  • Encephalitis
  • Pathology
  • World
  • Demand

The Japanese Encephalitis pipeline guide presents information on all active drugs currently being developed for Japanese Encephalitis.

  • Encephalitis
  • Pathology
  • Japan

2019 Future of Encephalitis R& D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments ##.

  • Drug Development
  • Encephalitis
  • Pathology
  • Pharmaceutical
  • Therapy

Japanese Encephalitis Therapeutics Pipeline Analysis, 2017 Chapter ##.

  • Drug Development
  • Encephalitis
  • Pathology
  • Therapy
  • Japan
  • Western Equine Encephalitis - Overview
  • EQUINE ENCEPHALITIS VACCINE - DRUG PROFILE

Similarly, the Universities' portfolio in Phase II stages comprises ## molecules, respectively.

  • Encephalitis
  • United States
  • World
  • Product Initiative
  • Akshaya
  • Encephalitis - Overview
  • Encephalitis - Overview

One of the causes of Granulomatous Amebic Encephalitis (GAE), a serious infection of the brain and spinal cord, is Balamuthia.

  • Encephalitis
  • Infectious Disease
  • United States
  • Product Initiative
  • CEL-SCI Corporation
  • TOP COMPANIES PARTICIPATING IN ENCEPHALITIS THERAPEUTICS CLINICAL TRIALS
  • Encephalitis Therapeutics, Global, Clinical Trials by Phase (%), 2016*

ENCEPHALITIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2019* CLINICAL TRIALS BY END POINT STATUS ENCEPHALITIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2019* ENCEPHALITIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2019* Sou

  • Blood Supply
  • Clinical Trial
  • Encephalitis
  • World
  • Product Initiative
  • Japanese Encephalitis - Therapeutics Assessment
  • Japanese Encephalitis - Dormant Projects

Similarly, the Universities' portfolio in Phase III, Preclinical and Discovery stages comprises ##, ## and ## molecules, respectively.

  • Encephalitis
  • Vaccine
  • Japan
  • Company Sales
  • Product Initiative
  • Western Equine Encephalitis - Overview
  • Western Equine Encephalitis - Drug Profiles

Similarly, the Universities' portfolio in Phase II stages comprises ## molecules, respectively.

  • Encephalitis
  • Vaccine
  • United States
  • World
  • Product Initiative
  • Japanese Encephalitis - Discontinued Products
  • Japanese Encephalitis - Drug Profiles

The molecules developed by Companies in Phase III, Phase I, Preclinical, Discovery and Unknown stages are ##, ##, ##, ## and ## respectively.

  • Encephalitis
  • Vaccine
  • Japan
  • Product Initiative
  • Kineta, Inc.
  • TICK BORNE ENCEPHALITIS THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY TRIAL STATUS, 2018*
  • TICK BORNE ENCEPHALITIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, KEY SPONSORS, 2018*

TICK BORNE ENCEPHALITIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2018* CLINICAL TRIALS BY END POINT STATUS TICK BORNE ENCEPHALITIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2018* TICK BORNE ENCEPHALITIS THERAPEUTICS CLINICAL TRIALS, GLOBA

  • Encephalitis
  • Vaccine
  • World
  • Product Initiative
  • Pfizer Inc.
  • Encephalitis - Overview
  • Encephalitis - Overview

One of the causes of Granulomatous Amebic Encephalitis (GAE), a serious infection of the brain and spinal cord, is Balamuthia.

  • Encephalitis
  • Infectious Disease
  • Pathology
  • Therapy
  • United States
  • ENCEPHALITIS THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY REGION (%), 2017*
  • TOP COMPANIES PARTICIPATING IN ENCEPHALITIS THERAPEUTICS CLINICAL TRIALS

ENCEPHALITIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* CLINICAL TRIALS BY END POINT STATUS ENCEPHALITIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* ENCEPHALITIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* End

  • Clinical Trial
  • Encephalitis
  • Neurology
  • Therapy
  • Sanofi S.A.

Global Encephalitis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets ## Table of Contents ##. ## List of Tables List of Figures ## Executive Summary ##. ## Encephalitis- Disease Overview ##. ## Encephalitis- Pipel

  • Clinical Trial
  • Drug Development
  • Encephalitis
  • Pharmaceutical
  • Therapy
  • JAPANESE ENCEPHALITIS THERAPEUTICS, G7 COUNTRIES, CLINICAL TRIALS BY PHASE, 2017*
  • JAPANESE ENCEPHALITIS THERAPEUTICS, GLOBAL, CLINICAL TRIALS IN PROGRESS BY PHASE, 2017*

JAPANESE ENCEPHALITIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2017* JAPANESE ENCEPHALITIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2017* JAPANESE ENCEPHALITIS THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2017* Com

  • Encephalitis
  • Pathology
  • Vaccine
  • Japan
  • Product Initiative

The report focuses on drugs and therapies being evaluated for Encephalitis treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Clinical Trial
  • Drug Development
  • Encephalitis
  • Pathology

Insights into Encephalitis Pipeline ##.

  • Encephalitis
  • Pathology
  • World

2019 Encephalitis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Clinical Trial
  • Encephalitis
  • Pathology
  • APAC
  • World

The report focuses on drugs and therapies being evaluated for Tick Borne Encephalitis treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Clinical Trial
  • Drug Development
  • Encephalitis
  • Pathology

Insights into Equine Encephalitis Infection Pipeline – ##.

  • Encephalitis
  • Infectious Disease
  • Pathology
  • World
  • Equine Encephalitis - Therapeutics Assessment
  • Equine Encephalitis Overview

Equine Encephalitis Overview PIPELINE PRODUCTS FOR EQUINE ENCEPHALITIS - OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR EQUINE ENCEPHALITIS, H## 2016 Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR EQUINE ENCEPHALITIS, H## 2016 NUMBER OF PRODUCT

  • Encephalitis
  • United States
  • Venezuela
  • World
  • Product Initiative

Insights into Equine Encephalitis Pipeline ##.

  • Encephalitis
  • Pathology
  • World

Insights into Eastern Equine Encephalitis Pipeline ##.

  • Encephalitis
  • Pathology
  • World

Insights into Western Equine Encephalitis Pipeline ##.

  • Encephalitis
  • Pathology
  • World

Insights into Eastern Equine Encephalitis Infection Pipeline – ##.

  • Encephalitis
  • Infectious Disease
  • Pathology
  • World

Insights into Western Equine Encephalitis Infection Pipeline – ##.

  • Encephalitis
  • Infectious Disease
  • Pathology
  • World

Equine Encephalitis - Pipeline Insight, 2019 ##.

  • Encephalitis
  • Therapy

2019 Japanese Encephalitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ##.

  • Clinical Trial
  • Drug Development
  • Encephalitis
  • Pathology
  • Japan

2019 Encephalitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ##.

  • Clinical Trial
  • Drug Development
  • Encephalitis
  • Pathology

2019 Tick Borne Encephalitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ##.

  • Clinical Trial
  • Drug Development
  • Encephalitis
  • Pathology